Hinge Health, Inc. (HNGE) Stock Forecast
Data as of Sep 16, 2026Healthcare · Current price $92.98 (+0.66%)
Price Target Range
Consensus Price Target Over Time
Analyst Rating Distribution
Last 3 Months
6-Month Trend
Latest Analyst Forecasts
Price targets issued by Wall Street analysts. Upside calculated against today's price.
| Date | Analyst | Firm | Price Target | Upside |
|---|---|---|---|---|
| Apr 8, 2026 | Elizabeth Anderson | Evercore ISI | $45.00 | -51.6% |
| Mar 11, 2026 | Rishi Jaluria | RBC Capital | $55.00 | -40.8% |
| Feb 11, 2026 | Rishi Jaluria | RBC Capital | $50.00 | -46.2% |
| Feb 11, 2026 | Elizabeth Anderson | Evercore ISI | $50.00 | -46.2% |
| Jan 8, 2026 | Stan Berenshteyn | Wells Fargo | $68.00 | -26.9% |
| Nov 5, 2025 | Jessica Tassan | Piper Sandler | $71.00 | -23.6% |
| Nov 5, 2025 | Saket Kalia | Barclays | $65.00 | -30.1% |
| Sep 5, 2025 | Vikram Kesavabhotla | Robert W. Baird | $56.00 | -39.8% |
| Jun 16, 2025 | Jessica Tassan | Piper Sandler | $41.00 | -55.9% |
| Jun 16, 2025 | David Grossman | Stifel Nicolaus | $48.00 | -48.4% |
| Jun 16, 2025 | Craig Hettenbach | Morgan Stanley | $46.00 | -50.5% |
| Jun 16, 2025 | Scott Schoenhaus | KeyBanc | $45.00 | -51.6% |
| Jun 16, 2025 | Saket Kalia | Barclays | $43.00 | -53.8% |
Top Analysts Covering HNGE
HNGE vs Sector & Market
| Metric | HNGE | Healthcare Avg | Large Cap Avg |
|---|---|---|---|
| Analyst Rating | 2.03 | 2.26 | 2.42 |
| Analyst Count | 32 | 8 | 18 |
| Target Upside | +11.5% | +16187.2% | +19.5% |
| P/E Ratio | -6.73 | 3.79 | 38.67 |
Revenue Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-12-31 | $733M | $738M | $744M | 11 |
| 2027-03-31 | $196M | $203M | $211M | 5 |
| 2027-06-30 | $204M | $211M | $219M | 5 |
| 2027-09-30 | $214M | $222M | $230M | 5 |
| 2027-12-31 | $225M | $233M | $242M | 5 |
| 2028-03-31 | $221M | $229M | $238M | 4 |
| 2028-06-30 | $235M | $244M | $253M | 4 |
| 2028-09-30 | $236M | $245M | $254M | 4 |
| 2028-12-31 | $240M | $248M | $258M | 4 |
| 2029-12-31 | $1.21B | $1.24B | $1.29B | 5 |
| 2030-12-31 | $1.38B | $1.41B | $1.48B | 3 |
EPS Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-12-31 | $1.70 | $1.95 | $2.08 | 8 |
| 2027-03-31 | $0.43 | $0.45 | $0.47 | 3 |
| 2027-06-30 | $0.49 | $0.51 | $0.53 | 5 |
| 2027-09-30 | $0.55 | $0.58 | $0.61 | 3 |
| 2027-12-31 | $0.64 | $0.68 | $0.71 | 6 |
| 2028-03-31 | $0.52 | $0.54 | $0.57 | 4 |
| 2028-06-30 | $0.63 | $0.66 | $0.69 | 6 |
| 2028-09-30 | $0.67 | $0.70 | $0.73 | 4 |
| 2028-12-31 | $0.71 | $0.74 | $0.78 | 7 |
| 2029-12-31 | $3.28 | $3.38 | $3.58 | 1 |
| 2030-12-31 | $3.67 | $3.79 | $4.02 | 1 |
Frequently Asked Questions
What is the analyst consensus for HNGE?
The consensus among 32 analysts covering Hinge Health, Inc. (HNGE) is Buy with an average price target of $77.17.
What is the highest price target for HNGE?
The highest price target for HNGE is $71.00, set by Jessica Tassan at Piper Sandler on 2025-11-05.
What is the lowest price target for HNGE?
The lowest price target for HNGE is $41.00, set by Jessica Tassan at Piper Sandler on 2025-06-16.
How many analysts cover HNGE?
32 analysts have issued ratings for Hinge Health, Inc. in the past 12 months.
Is HNGE a buy or sell right now?
Based on 32 analyst ratings, HNGE has a consensus rating of Buy (2.03/5) with a +11.5% upside to the consensus target of $77.17.
What are the earnings estimates for HNGE?
Analysts estimate HNGE will report EPS of $1.95 for the period ending 2026-12-31, with revenue estimated at $738M.
Related Stock Forecasts
Data updated daily. Analyst price targets sourced from public filings and broker reports. Not investment advice.